56th Clinical Diabetes & Endocrinology Institute (CDEI) Annual CME Conference
56th Clinical Diabetes & Endocrinology Institute (CDEI) Annual CME Conference is organized by Clinical Diabetes and Endocrinology Institute (CDEI) and will be held from Jan 11 - 14, 2020 at Aspen Snowmass, Snowmass Village, Colorado, United States of America. This conference has been approved for a maximum of 18 AMA PRA Category 1 Credit(s)™.
This activity is intended for endocrinologists, primary care physicians, fellow, physician assistants, nurse practitioners, nurses and other health care professionals with an interest in diabetes, endocrinology and metabolism.
Who Should Attend:
Endocrinologist, primary care physicians, fellows, physician assistants, nurse practitioners, nurses and other health care professionals with an interest in diabetes, endocrinology and metabolism.
The 56th Annual Clinical Diabetes and Endocrinology Institute CME Conference will address key topics in endocrinology including diabetes technology, hyperandrogenism, adrenal disorders, hypertriglyceridemia, thyroid nodules and abnormal thyroid function testing, medical and surgical options for endocrine tumors, pituitary disorders, bone density imaging and therapies for osteoporosis, hypogonadism, cardiovascular disease in diabetes, complexities in diabetes care, and more. Join expert faculty for a highly interactive CME conference now in its 56th year.
After completing this activity, the participant should be better able to:
• Describe the diagnosis, evaluation and management of primary hyperaldosteronism with more subtle clinical presentations
• Apply a step-wise approach to diagnose and treat patients with hyperaldosteronism
• Discuss evidence-based screening and evaluation of patients with adrenal incidentaloma or endocrine hypertension
• Outline the evaluation and management of pituitary hormone deficiency and pituitary tumors including those that produce growth hormone
• Describe the evidence used to guide management of thyroid nodules
• Outline the evidence for evaluation and management of thyroid cancer including thyroid surgery
• Evaluate and interpret abnormal thyroid function tests
• Discuss important factors needed to distinguish among different therapies in management of diabetes in patients with varying comorbidities and risk profiles
• Formulate management plans for patients with diabetes with varying comorbidities and risk profiles
• Describe the use of diabetes technologies in management of diabetes, including the use of insulin pumps, continuous glucose monitoring, and other technologies in types 1 and 2 diabetes
• Describe recent data regarding diabetes and heart failure
• Use the latest evidence to evaluate and manage cardiovascular risk in diabetes and metabolic disorders
• Explain the relative role and impact of genes versus the environment in type 2 diabetes
• Outline evidence from recent relevant studies of testosterone therapy and potential adverse effects in men
• Describe the evaluation of women for causes of hyperandrogenism
• Use the best available evidence to guide therapy for PCOS and CAH
• Describe the interpretation of bone density studies
• Formulate osteoporosis treatment in the context of currently available anabolic and antiresorptive therapies
• Discuss the role of sex steroids in bone metabolism
• Interpret laboratory testing for lipid disorders
• Outline the evaluation for lipid disorders and strategies for managing severe hypercholesterolemia, severe hypertriglyceridemia and atherogenic dyslipidemia
Additional details will be posted as soon as the information is available.
|Contact No. :|
|Registration Type||Last Date||Price|
|MD/DO/PhD/PharmD Fee||10 Jan,2020||USD 820.00|
|NP/PA/RN/CDE/RPh/Other Fee||10 Jan,2020||USD 520.00|
|Trainee Fee||10 Jan,2020||USD 350.00|
The Westin Snowmass Resort,
100 Elbert Ln,
Snowmass, Colorado, United States of America 81615,
40 Elbert Ln,
Snowmass Village, Colorado, United States of America 81615,